Catalyst Wire Dossier Catalyst Wire Dossier

iSCLife®-ONFH

human umbilical cord mesenchymal stem cells · Sclnow Biotechnology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iSCLife®-ONFH, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH) [Phase 1, Phase 2]

See pricing